Search clinical trials for: GSK2330811

Total 4 results

GlaxoSmithKline

Completed

Proof of Mechanism Study of GSK2330811 in Diffuse Cutaneous Systemic Sclerosis

Scleroderma, Systemic

United States, United Kingdom, Netherlands, Canada
GlaxoSmithKline

Completed

A Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of GSK2330811 in Healthy Subjects

Scleroderma, Systemic

United Kingdom
GlaxoSmithKline

Withdrawn

Study to Evaluate Safety, Tolerability and Efficacy of GSK2330811 in Crohn's Disease (COSMIS)

Crohn's Disease | Crohns Disease
GlaxoSmithKline

Completed

Safety, Tolerability, Pharmacokinetics, Pharmacodynamics of GSK2330811 in Healthy Japanese Participants

Healthy Volunteers

United Kingdom

3

Subscribe